AG

Arumugam Gunasekaran

Active Director Managing Director DIN 08346154
DIN 08346154 First appointment Jan 2019 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Arumugam Gunasekaran

Data last updated:

Arumugam Gunasekaran is a Managing Director at Sai Soulcare Pharma Private Limited (since 2019). The company operates in Business Services.

DIN 08346154
Primary Designation Managing Director
Industry Business Services
First Appointment 29 Jan 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sai Soulcare Pharma Private Limited U74999TZ2019PTC031616
Managing Director29 Jan 20192019Active

Board colleagues of Arumugam Gunasekaran

Directorship timeline

Open interactive timeline →
Sai Soulcare Pharma Private Limited
Premium access

Shareholding and investment profile for Arumugam Gunasekaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arumugam Gunasekaran

Arumugam Gunasekaran currently holds 1 directorship: Sai Soulcare Pharma Private Limited (Managing Director, since 29 Jan 2019).

Arumugam Gunasekaran was first appointed on 29 Jan 2019 as Managing Director at Sai Soulcare Pharma Private Limited.

The current boards of Arumugam Gunasekaran's companies include Kuppuraj Elango (Sai Soulcare Pharma Private Limited), Panneerselvam Dineshkumar (Sai Soulcare Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available